Fortrea (NASDAQ:FTRE) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Fortrea (NASDAQ:FTRE - Get Free Report) issued its quarterly earnings data on Friday. The company reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.02), RTT News reports. The company had revenue of $674.90 million during the quarter, compared to the consensus estimate of $674.86 million. Fortrea had a negative net margin of 10.09% and a positive return on equity of 1.98%. Fortrea's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.24 earnings per share. Fortrea updated its FY 2024 guidance to EPS.

Fortrea Stock Up 32.2 %

NASDAQ FTRE traded up $5.81 during trading hours on Friday, hitting $23.86. The company's stock had a trading volume of 5,074,060 shares, compared to its average volume of 1,288,370. The company's 50-day simple moving average is $19.69 and its two-hundred day simple moving average is $24.25. Fortrea has a 52 week low of $16.53 and a 52 week high of $41.02. The company has a market capitalization of $2.14 billion, a PE ratio of -7.30, a price-to-earnings-growth ratio of 2.72 and a beta of 0.70. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

Wall Street Analysts Forecast Growth

FTRE has been the subject of several recent research reports. TD Cowen cut their price target on Fortrea from $27.00 to $23.00 and set a "hold" rating for the company in a research note on Tuesday, August 13th. Deutsche Bank Aktiengesellschaft decreased their price target on Fortrea from $28.00 to $23.00 and set a "hold" rating on the stock in a research report on Tuesday, August 20th. William Blair reiterated a "market perform" rating on shares of Fortrea in a research note on Friday. Bank of America dropped their target price on shares of Fortrea from $26.00 to $21.00 and set an "underperform" rating for the company in a research report on Tuesday, August 13th. Finally, Evercore ISI decreased their target price on Fortrea from $22.00 to $20.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $23.60.

Fortrea Company Profile

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.